Pharmabiz3h
Adcentrx begins patient dosing in phase 1a/b study of ADRX-0405, a potential first-in-class ADC targeting STEAP1 to treat advanced solid tumours
Adcentrx begins patient dosing in phase 1a/b study of ADRX-0405, a potential first-in-class ADC targeting STEAP1 to treat advanced solid tumours: San Diego, California Wednesday, ...
Pharmabiz4h
No need to get anxious over HMPV virus infection, it is not dangerous like coronavirus: Experts
No need to get anxious over HMPV virus infection, it is not dangerous like coronavirus: Experts: Our Bureau, Chennai Wednesday, January 8, 2025, 16:45 Hrs [IST] Although two cases ...
Pharmabiz4h
Medanta strengthens its Renal Care Institute, appoints leading urologist Dr Sanjay Gogoi as chairman
Medanta strengthens its Renal Care Institute, appoints leading urologist Dr Sanjay Gogoi as chairman: Our Bureau, Mumbai Wednesday, January 8, 2025, 16:15 Hrs [IST] Reinforcing it ...
Pharmabiz7h
AIOCD seeks Ministry of Railways to withdraw plans to rope in online pharmacies for home delivery of medicines
AIOCD seeks Ministry of Railways to withdraw plans to rope in online pharmacies for home delivery of medicines: Our Bureau, New Delhi Wednesday, January 8, 2025, 14:10 Hrs [IST] T ...
Pharmabiz7h
US FDA issues new draft guidance aimed to help improve performance of pulse oximeters across skin tones
US FDA issues new draft guidance aimed to help improve performance of pulse oximeters across skin tones: Maryland Wednesday, January 8, 2025, 14:00 Hrs [IST] The US Food and Drug ...
Pharmabiz7h
Rajya Sabha MP seeks health ministry to use powers to support local manufacturing of SMA drug risdiplam
Our Bureau, New Delhi Wednesday, January 8, 2025, 13:50 Hrs [IST] ...
Pharmabiz8h
Arcturus Therapeutics initiates patient dosing in phase 2 multiple ascending dose studies for CF and OTC deficiency
Arcturus Therapeutics initiates patient dosing in phase 2 multiple ascending dose studies for CF and OTC deficiency: San Diego Wednesday, January 8, 2025, 13:00 Hrs [IST] Arcturus ...
Pharmabiz10h
US FDA issues comprehensive draft guidance for developers of AI -enabled medical devices
US FDA issues comprehensive draft guidance for developers of AI -enabled medical devices: Maryland Wednesday, January 8, 2025, 11:00 Hrs [IST] The US Food and Drug Administration ...
Pharmabiz11h
US FDA grants breakthrough therapy designation to GSK’s B7-H3-targeted ADC, GSK’227 to treat relapsed or refractory osteosarcoma
US FDA grants breakthrough therapy designation to GSK’s B7-H3-targeted ADC, GSK’227 to treat relapsed or refractory osteosarcoma: London, UK Wednesday, January 8, 2025, 10:00 ...
Pharmabiz12h
MTaI to host MedTekon 2025 in New Delhi on January 30
Our Bureau, New Delhi Wednesday, January 8, 2025, 09:00 Hrs [IST] Medical Technology Association of India (MTaI), which repr ...
Pharmabiz13h
Govt yet to notify rules for compounding offences as per amendments introduced through Jan Vishwas Act
Govt yet to notify rules for compounding offences as per amendments introduced through Jan Vishwas Act: Shardul Nautiyal, Mumbai Wednesday, January 8, 2025, 08:00 Hrs [IST] Despit ...
Pharmabiz13h
Govt must adopt a pragmatic approach on revised Schedule M similar to US FDA compliance: Manoj Palrecha
Govt must adopt a pragmatic approach on revised Schedule M similar to US FDA compliance: Manoj Palrecha: Nandita Vijayasimha, Bengaluru Wednesday, January 8, 2025, 08:00 Hrs [IST] ...